Intrinsic Value

Krystal Biotech, Inc. (KRYS)


+7.36 (+6.30%)

Enterprise Value -
Net Debt -152.97
Equity Value -
Shares Outstanding 25.49
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt